ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chronic Urticaria Medicine Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-8U18064
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Chronic Urticaria Medicine Market Research Report 2024
BUY CHAPTERS

Global Chronic Urticaria Medicine Market Research Report 2024

Code: QYRE-Auto-8U18064
Report
August 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Fresenius
Merck
Johnson & Johnson
3SBio Inc
Sun Pharmaceutical Industries
Yangtze River Pharmaceutical Group
CSPC Pharmaceutical Group
Shanxi C&Y Pharmaceutical Group
Lianhuan Pharma
Jiudian Pharmaceutical
SPHBIO

Chronic Urticaria Medicine Market

Chronic Urticaria Medicine refers to the specific medications used in the management of chronic urticaria, also known as chronic hives,Mainly including Antihistamines,H2 Antagonists,Leukotriene Receptor Antagonists,Corticosteroids,Immunosuppressant and Biologics.
The global Chronic Urticaria Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Chronic Urticaria Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Urticaria Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chronic Urticaria Medicine include Johnson & Johnson, Merck, Fresenius, 3SBIO, SPHBIO, Sun Pharmaceutical Industries, Yangtze River Pharmaceutical Group, CSPC Pharmaceutical Group, Shanxi C&Y Pharmaceutical Group, Lianhuan Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Urticaria Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Urticaria Medicine.
The Chronic Urticaria Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Chronic Urticaria Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Urticaria Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Chronic Urticaria Medicine Market Report

Report Metric Details
Report Name Chronic Urticaria Medicine Market
Segment by Type
Segment by Application
  • Hospital and Clinic
  • Specialist Medical Centre
  • Retail Pharmacies
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, Merck, Fresenius, 3SBIO, SPHBIO, Sun Pharmaceutical Industries, Yangtze River Pharmaceutical Group, CSPC Pharmaceutical Group, Shanxi C&Y Pharmaceutical Group, Lianhuan Pharma, Jiudian Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Chronic Urticaria Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Chronic Urticaria Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Chronic Urticaria Medicine Market report?

Ans: The main players in the Chronic Urticaria Medicine Market are Johnson & Johnson, Merck, Fresenius, 3SBIO, SPHBIO, Sun Pharmaceutical Industries, Yangtze River Pharmaceutical Group, CSPC Pharmaceutical Group, Shanxi C&Y Pharmaceutical Group, Lianhuan Pharma, Jiudian Pharmaceutical

What are the Application segmentation covered in the Chronic Urticaria Medicine Market report?

Ans: The Applications covered in the Chronic Urticaria Medicine Market report are Hospital and Clinic, Specialist Medical Centre, Retail Pharmacies, Other

What are the Type segmentation covered in the Chronic Urticaria Medicine Market report?

Ans: The Types covered in the Chronic Urticaria Medicine Market report are Loratadine, Desloratadine, Fexofenadine, Ebastine, Stastine, Cetirizine, Levocetirizine, Cinnarizine, Other

Recommended Reports

Allergy Medication Markets

Specialized Allergy Drugs

Antihistamines & Diagnostics

1 Chronic Urticaria Medicine Market Overview
1.1 Product Definition
1.2 Chronic Urticaria Medicine by Type
1.2.1 Global Chronic Urticaria Medicine Market Value Comparison by Type (2024-2030)
1.2.2 Loratadine
1.2.3 Desloratadine
1.2.4 Fexofenadine
1.2.5 Ebastine
1.2.6 Stastine
1.2.7 Cetirizine
1.2.8 Levocetirizine
1.2.9 Cinnarizine
1.2.10 Other
1.3 Chronic Urticaria Medicine by Application
1.3.1 Global Chronic Urticaria Medicine Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Specialist Medical Centre
1.3.4 Retail Pharmacies
1.3.5 Other
1.4 Global Chronic Urticaria Medicine Market Size Estimates and Forecasts
1.4.1 Global Chronic Urticaria Medicine Revenue 2019-2030
1.4.2 Global Chronic Urticaria Medicine Sales 2019-2030
1.4.3 Global Chronic Urticaria Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chronic Urticaria Medicine Market Competition by Manufacturers
2.1 Global Chronic Urticaria Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chronic Urticaria Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chronic Urticaria Medicine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Chronic Urticaria Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chronic Urticaria Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chronic Urticaria Medicine, Product Type & Application
2.7 Global Key Manufacturers of Chronic Urticaria Medicine, Date of Enter into This Industry
2.8 Global Chronic Urticaria Medicine Market Competitive Situation and Trends
2.8.1 Global Chronic Urticaria Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Chronic Urticaria Medicine Players Market Share by Revenue
2.8.3 Global Chronic Urticaria Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Chronic Urticaria Medicine Market Scenario by Region
3.1 Global Chronic Urticaria Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chronic Urticaria Medicine Sales by Region: 2019-2030
3.2.1 Global Chronic Urticaria Medicine Sales by Region: 2019-2024
3.2.2 Global Chronic Urticaria Medicine Sales by Region: 2025-2030
3.3 Global Chronic Urticaria Medicine Revenue by Region: 2019-2030
3.3.1 Global Chronic Urticaria Medicine Revenue by Region: 2019-2024
3.3.2 Global Chronic Urticaria Medicine Revenue by Region: 2025-2030
3.4 North America Chronic Urticaria Medicine Market Facts & Figures by Country
3.4.1 North America Chronic Urticaria Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chronic Urticaria Medicine Sales by Country (2019-2030)
3.4.3 North America Chronic Urticaria Medicine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chronic Urticaria Medicine Market Facts & Figures by Country
3.5.1 Europe Chronic Urticaria Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chronic Urticaria Medicine Sales by Country (2019-2030)
3.5.3 Europe Chronic Urticaria Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chronic Urticaria Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Chronic Urticaria Medicine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chronic Urticaria Medicine Sales by Region (2019-2030)
3.6.3 Asia Pacific Chronic Urticaria Medicine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Chronic Urticaria Medicine Market Facts & Figures by Country
3.7.1 Latin America Chronic Urticaria Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chronic Urticaria Medicine Sales by Country (2019-2030)
3.7.3 Latin America Chronic Urticaria Medicine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Chronic Urticaria Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Urticaria Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chronic Urticaria Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chronic Urticaria Medicine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chronic Urticaria Medicine Sales by Type (2019-2030)
4.1.1 Global Chronic Urticaria Medicine Sales by Type (2019-2024)
4.1.2 Global Chronic Urticaria Medicine Sales by Type (2025-2030)
4.1.3 Global Chronic Urticaria Medicine Sales Market Share by Type (2019-2030)
4.2 Global Chronic Urticaria Medicine Revenue by Type (2019-2030)
4.2.1 Global Chronic Urticaria Medicine Revenue by Type (2019-2024)
4.2.2 Global Chronic Urticaria Medicine Revenue by Type (2025-2030)
4.2.3 Global Chronic Urticaria Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Chronic Urticaria Medicine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chronic Urticaria Medicine Sales by Application (2019-2030)
5.1.1 Global Chronic Urticaria Medicine Sales by Application (2019-2024)
5.1.2 Global Chronic Urticaria Medicine Sales by Application (2025-2030)
5.1.3 Global Chronic Urticaria Medicine Sales Market Share by Application (2019-2030)
5.2 Global Chronic Urticaria Medicine Revenue by Application (2019-2030)
5.2.1 Global Chronic Urticaria Medicine Revenue by Application (2019-2024)
5.2.2 Global Chronic Urticaria Medicine Revenue by Application (2025-2030)
5.2.3 Global Chronic Urticaria Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Chronic Urticaria Medicine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Chronic Urticaria Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Chronic Urticaria Medicine Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Chronic Urticaria Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Chronic Urticaria Medicine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Fresenius
6.3.1 Fresenius Company Information
6.3.2 Fresenius Description and Business Overview
6.3.3 Fresenius Chronic Urticaria Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Chronic Urticaria Medicine Product Portfolio
6.3.5 Fresenius Recent Developments/Updates
6.4 3SBIO
6.4.1 3SBIO Company Information
6.4.2 3SBIO Description and Business Overview
6.4.3 3SBIO Chronic Urticaria Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 3SBIO Chronic Urticaria Medicine Product Portfolio
6.4.5 3SBIO Recent Developments/Updates
6.5 SPHBIO
6.5.1 SPHBIO Company Information
6.5.2 SPHBIO Description and Business Overview
6.5.3 SPHBIO Chronic Urticaria Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SPHBIO Chronic Urticaria Medicine Product Portfolio
6.5.5 SPHBIO Recent Developments/Updates
6.6 Sun Pharmaceutical Industries
6.6.1 Sun Pharmaceutical Industries Company Information
6.6.2 Sun Pharmaceutical Industries Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Chronic Urticaria Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Industries Chronic Urticaria Medicine Product Portfolio
6.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.7 Yangtze River Pharmaceutical Group
6.7.1 Yangtze River Pharmaceutical Group Company Information
6.7.2 Yangtze River Pharmaceutical Group Description and Business Overview
6.7.3 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Product Portfolio
6.7.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
6.8 CSPC Pharmaceutical Group
6.8.1 CSPC Pharmaceutical Group Company Information
6.8.2 CSPC Pharmaceutical Group Description and Business Overview
6.8.3 CSPC Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CSPC Pharmaceutical Group Chronic Urticaria Medicine Product Portfolio
6.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.9 Shanxi C&Y Pharmaceutical Group
6.9.1 Shanxi C&Y Pharmaceutical Group Company Information
6.9.2 Shanxi C&Y Pharmaceutical Group Description and Business Overview
6.9.3 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Product Portfolio
6.9.5 Shanxi C&Y Pharmaceutical Group Recent Developments/Updates
6.10 Lianhuan Pharma
6.10.1 Lianhuan Pharma Company Information
6.10.2 Lianhuan Pharma Description and Business Overview
6.10.3 Lianhuan Pharma Chronic Urticaria Medicine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lianhuan Pharma Chronic Urticaria Medicine Product Portfolio
6.10.5 Lianhuan Pharma Recent Developments/Updates
6.11 Jiudian Pharmaceutical
6.11.1 Jiudian Pharmaceutical Company Information
6.11.2 Jiudian Pharmaceutical Description and Business Overview
6.11.3 Jiudian Pharmaceutical Chronic Urticaria Medicine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jiudian Pharmaceutical Chronic Urticaria Medicine Product Portfolio
6.11.5 Jiudian Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Urticaria Medicine Industry Chain Analysis
7.2 Chronic Urticaria Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Urticaria Medicine Production Mode & Process
7.4 Chronic Urticaria Medicine Sales and Marketing
7.4.1 Chronic Urticaria Medicine Sales Channels
7.4.2 Chronic Urticaria Medicine Distributors
7.5 Chronic Urticaria Medicine Customers
8 Chronic Urticaria Medicine Market Dynamics
8.1 Chronic Urticaria Medicine Industry Trends
8.2 Chronic Urticaria Medicine Market Drivers
8.3 Chronic Urticaria Medicine Market Challenges
8.4 Chronic Urticaria Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Fresenius
Merck
Johnson & Johnson
3SBio Inc
Sun Pharmaceutical Industries
Yangtze River Pharmaceutical Group
CSPC Pharmaceutical Group
Shanxi C&Y Pharmaceutical Group
Lianhuan Pharma
Jiudian Pharmaceutical
SPHBIO
List of Tables
 Table 1. Global Chronic Urticaria Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Chronic Urticaria Medicine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Chronic Urticaria Medicine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Chronic Urticaria Medicine Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Chronic Urticaria Medicine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Chronic Urticaria Medicine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Chronic Urticaria Medicine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Chronic Urticaria Medicine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Chronic Urticaria Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Chronic Urticaria Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Chronic Urticaria Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Chronic Urticaria Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Chronic Urticaria Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Urticaria Medicine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Chronic Urticaria Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Chronic Urticaria Medicine Sales by Region (2019-2024) & (K Units)
 Table 18. Global Chronic Urticaria Medicine Sales Market Share by Region (2019-2024)
 Table 19. Global Chronic Urticaria Medicine Sales by Region (2025-2030) & (K Units)
 Table 20. Global Chronic Urticaria Medicine Sales Market Share by Region (2025-2030)
 Table 21. Global Chronic Urticaria Medicine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Chronic Urticaria Medicine Revenue Market Share by Region (2019-2024)
 Table 23. Global Chronic Urticaria Medicine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Chronic Urticaria Medicine Revenue Market Share by Region (2025-2030)
 Table 25. North America Chronic Urticaria Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Chronic Urticaria Medicine Sales by Country (2019-2024) & (K Units)
 Table 27. North America Chronic Urticaria Medicine Sales by Country (2025-2030) & (K Units)
 Table 28. North America Chronic Urticaria Medicine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Chronic Urticaria Medicine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Chronic Urticaria Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Chronic Urticaria Medicine Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Chronic Urticaria Medicine Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Chronic Urticaria Medicine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Chronic Urticaria Medicine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Chronic Urticaria Medicine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Chronic Urticaria Medicine Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Chronic Urticaria Medicine Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Chronic Urticaria Medicine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Chronic Urticaria Medicine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Chronic Urticaria Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Chronic Urticaria Medicine Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Chronic Urticaria Medicine Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Chronic Urticaria Medicine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Chronic Urticaria Medicine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Chronic Urticaria Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Chronic Urticaria Medicine Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Chronic Urticaria Medicine Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Chronic Urticaria Medicine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Chronic Urticaria Medicine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Chronic Urticaria Medicine Sales (K Units) by Type (2019-2024)
 Table 51. Global Chronic Urticaria Medicine Sales (K Units) by Type (2025-2030)
 Table 52. Global Chronic Urticaria Medicine Sales Market Share by Type (2019-2024)
 Table 53. Global Chronic Urticaria Medicine Sales Market Share by Type (2025-2030)
 Table 54. Global Chronic Urticaria Medicine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Chronic Urticaria Medicine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Chronic Urticaria Medicine Revenue Market Share by Type (2019-2024)
 Table 57. Global Chronic Urticaria Medicine Revenue Market Share by Type (2025-2030)
 Table 58. Global Chronic Urticaria Medicine Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Chronic Urticaria Medicine Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Chronic Urticaria Medicine Sales (K Units) by Application (2019-2024)
 Table 61. Global Chronic Urticaria Medicine Sales (K Units) by Application (2025-2030)
 Table 62. Global Chronic Urticaria Medicine Sales Market Share by Application (2019-2024)
 Table 63. Global Chronic Urticaria Medicine Sales Market Share by Application (2025-2030)
 Table 64. Global Chronic Urticaria Medicine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Chronic Urticaria Medicine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Chronic Urticaria Medicine Revenue Market Share by Application (2019-2024)
 Table 67. Global Chronic Urticaria Medicine Revenue Market Share by Application (2025-2030)
 Table 68. Global Chronic Urticaria Medicine Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Chronic Urticaria Medicine Price (US$/Unit) by Application (2025-2030)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Johnson & Johnson Chronic Urticaria Medicine Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Merck Chronic Urticaria Medicine Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Fresenius Company Information
 Table 81. Fresenius Description and Business Overview
 Table 82. Fresenius Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Fresenius Chronic Urticaria Medicine Product
 Table 84. Fresenius Recent Developments/Updates
 Table 85. 3SBIO Company Information
 Table 86. 3SBIO Description and Business Overview
 Table 87. 3SBIO Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. 3SBIO Chronic Urticaria Medicine Product
 Table 89. 3SBIO Recent Developments/Updates
 Table 90. SPHBIO Company Information
 Table 91. SPHBIO Description and Business Overview
 Table 92. SPHBIO Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. SPHBIO Chronic Urticaria Medicine Product
 Table 94. SPHBIO Recent Developments/Updates
 Table 95. Sun Pharmaceutical Industries Company Information
 Table 96. Sun Pharmaceutical Industries Description and Business Overview
 Table 97. Sun Pharmaceutical Industries Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Sun Pharmaceutical Industries Chronic Urticaria Medicine Product
 Table 99. Sun Pharmaceutical Industries Recent Developments/Updates
 Table 100. Yangtze River Pharmaceutical Group Company Information
 Table 101. Yangtze River Pharmaceutical Group Description and Business Overview
 Table 102. Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Product
 Table 104. Yangtze River Pharmaceutical Group Recent Developments/Updates
 Table 105. CSPC Pharmaceutical Group Company Information
 Table 106. CSPC Pharmaceutical Group Description and Business Overview
 Table 107. CSPC Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. CSPC Pharmaceutical Group Chronic Urticaria Medicine Product
 Table 109. CSPC Pharmaceutical Group Recent Developments/Updates
 Table 110. Shanxi C&Y Pharmaceutical Group Company Information
 Table 111. Shanxi C&Y Pharmaceutical Group Description and Business Overview
 Table 112. Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Product
 Table 114. Shanxi C&Y Pharmaceutical Group Recent Developments/Updates
 Table 115. Lianhuan Pharma Company Information
 Table 116. Lianhuan Pharma Description and Business Overview
 Table 117. Lianhuan Pharma Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Lianhuan Pharma Chronic Urticaria Medicine Product
 Table 119. Lianhuan Pharma Recent Developments/Updates
 Table 120. Jiudian Pharmaceutical Company Information
 Table 121. Jiudian Pharmaceutical Description and Business Overview
 Table 122. Jiudian Pharmaceutical Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Jiudian Pharmaceutical Chronic Urticaria Medicine Product
 Table 124. Jiudian Pharmaceutical Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Chronic Urticaria Medicine Distributors List
 Table 128. Chronic Urticaria Medicine Customers List
 Table 129. Chronic Urticaria Medicine Market Trends
 Table 130. Chronic Urticaria Medicine Market Drivers
 Table 131. Chronic Urticaria Medicine Market Challenges
 Table 132. Chronic Urticaria Medicine Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Chronic Urticaria Medicine
 Figure 2. Global Chronic Urticaria Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Chronic Urticaria Medicine Market Share by Type: 2023 & 2030
 Figure 4. Loratadine Product Picture
 Figure 5. Desloratadine Product Picture
 Figure 6. Fexofenadine Product Picture
 Figure 7. Ebastine Product Picture
 Figure 8. Stastine Product Picture
 Figure 9. Cetirizine Product Picture
 Figure 10. Levocetirizine Product Picture
 Figure 11. Cinnarizine Product Picture
 Figure 12. Other Product Picture
 Figure 13. Global Chronic Urticaria Medicine Market Value by Application (2024-2030) & (US$ Million)
 Figure 14. Global Chronic Urticaria Medicine Market Share by Application: 2023 & 2030
 Figure 15. Hospital and Clinic
 Figure 16. Specialist Medical Centre
 Figure 17. Retail Pharmacies
 Figure 18. Other
 Figure 19. Global Chronic Urticaria Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 20. Global Chronic Urticaria Medicine Market Size (2019-2030) & (US$ Million)
 Figure 21. Global Chronic Urticaria Medicine Sales (2019-2030) & (K Units)
 Figure 22. Global Chronic Urticaria Medicine Average Price (US$/Unit) & (2019-2030)
 Figure 23. Chronic Urticaria Medicine Report Years Considered
 Figure 24. Chronic Urticaria Medicine Sales Share by Manufacturers in 2023
 Figure 25. Global Chronic Urticaria Medicine Revenue Share by Manufacturers in 2023
 Figure 26. Global 5 and 10 Largest Chronic Urticaria Medicine Players: Market Share by Revenue in Chronic Urticaria Medicine in 2023
 Figure 27. Chronic Urticaria Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 28. Global Chronic Urticaria Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 29. North America Chronic Urticaria Medicine Sales Market Share by Country (2019-2030)
 Figure 30. North America Chronic Urticaria Medicine Revenue Market Share by Country (2019-2030)
 Figure 31. United States Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Canada Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Europe Chronic Urticaria Medicine Sales Market Share by Country (2019-2030)
 Figure 34. Europe Chronic Urticaria Medicine Revenue Market Share by Country (2019-2030)
 Figure 35. Germany Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. France Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. U.K. Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Italy Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Russia Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Asia Pacific Chronic Urticaria Medicine Sales Market Share by Region (2019-2030)
 Figure 41. Asia Pacific Chronic Urticaria Medicine Revenue Market Share by Region (2019-2030)
 Figure 42. China Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Japan Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. South Korea Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. India Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Australia Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. China Taiwan Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Southeast Asia Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Latin America Chronic Urticaria Medicine Sales Market Share by Country (2019-2030)
 Figure 50. Mexico Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Brazil Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Argentina Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Colombia Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Middle East and Africa Chronic Urticaria Medicine Sales Market Share by Country (2019-2030)
 Figure 55. Middle East and Africa Chronic Urticaria Medicine Revenue Market Share by Country (2019-2030)
 Figure 56. Turkey Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 57. Saudi Arabia Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 58. UAE Chronic Urticaria Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 59. Global Sales Market Share of Chronic Urticaria Medicine by Type (2019-2030)
 Figure 60. Global Revenue Market Share of Chronic Urticaria Medicine by Type (2019-2030)
 Figure 61. Global Chronic Urticaria Medicine Price (US$/Unit) by Type (2019-2030)
 Figure 62. Global Sales Market Share of Chronic Urticaria Medicine by Application (2019-2030)
 Figure 63. Global Revenue Market Share of Chronic Urticaria Medicine by Application (2019-2030)
 Figure 64. Global Chronic Urticaria Medicine Price (US$/Unit) by Application (2019-2030)
 Figure 65. Chronic Urticaria Medicine Value Chain
 Figure 66. Chronic Urticaria Medicine Production Process
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Chronic Urticaria Or Hives Drug Market Research Report 2025
Global Chronic Idiopathic Urticaria Treatment Market Research Report 2024
Chronic Spontaneous Urticaria Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti allergic Drugs Market Research Report 2025
Global Hay Fever Drug Market Research Report 2025
Urticaria Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antihistamine Medications Market Research Report 2025
Global Allergy Medicine Market Research Report 2024
Global Papular Urticaria Drug Market Research Report 2024
Global Allergy Treatment Loratadine Market Research Report 2024
Global Drugs to Treat Allergic Diseases Market Research Report 2024
Global Allergy Treatment Drugs Market Research Report 2025
Global Allergy Diagnostic and Treatment Market Research Report 2024
Global Loratadine Market Insights Forecast to 2030
Global Allergy and Sinus Medicine Market Research Report 2025
Global Chronic Spontaneous Urticaria Drug Treatment Market Research Report 2024
Global Antihistamine Loratadine Market Research Report 2024
Global Pharma and Cetirizine OTC Market Research Report 2024
Global Allergic Rhinitis Immunotherapies Market Research Report 2024
Cetirizine Hydrochloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Chronic Idiopathic Urticaria Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38H16391
Tue Sep 23 00:00:00 UTC 2025

Add to Cart

Global Fungal Skin Disease Diagnostic Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17T16810
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Global UVB Vitiligo Phototherapy Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z16496
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Global Vitiligo Phototherapy Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15I16746
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions